Rapid Medtech Communications Limited 10463739 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is exhibition and fair organisers. Digita Accounts Production Advanced 6.30.9574.0 true 10463739 2024-01-01 2024-12-31 10463739 2024-12-31 10463739 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments 2024-12-31 10463739 core:CurrentFinancialInstruments 2024-12-31 10463739 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 10463739 bus:SmallEntities 2024-01-01 2024-12-31 10463739 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 10463739 bus:FilletedAccounts 2024-01-01 2024-12-31 10463739 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 10463739 bus:RegisteredOffice 2024-01-01 2024-12-31 10463739 bus:Director1 2024-01-01 2024-12-31 10463739 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 10463739 countries:EnglandWales 2024-01-01 2024-12-31 10463739 2023-01-01 2023-12-31 10463739 2023-12-31 10463739 core:CurrentFinancialInstruments 2023-12-31 10463739 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 10463739

Rapid Medtech Communications Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Rapid Medtech Communications Limited

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 4

 

Rapid Medtech Communications Limited

(Registration number: 10463739)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Other financial assets

4

-

50,000

Current assets

 

Debtors

5

408,310

358,510

Cash at bank and in hand

 

25,859

36,239

 

434,169

394,749

Creditors: Amounts falling due within one year

6

(364,076)

(383,583)

Net current assets

 

70,093

11,166

Net assets

 

70,093

61,166

Capital and reserves

 

Called up share capital

100

100

Retained earnings

69,993

61,066

Shareholders' funds

 

70,093

61,166

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 9 July 2025 and signed on its behalf by:
 

.........................................
Sir N D Burney
Director

 

Rapid Medtech Communications Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Regus House
Heronsway
Chester Business Park
Chester
Cheshire
CH4 9QR

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

 

Rapid Medtech Communications Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

4

Other financial assets (current and non-current)

Financial assets at cost less impairment
£

Total
£

Non-current financial assets

Cost or valuation

At 1 January 2024

50,000

50,000

Disposals

(50,000)

(50,000)

At 31 December 2024

-

-

Impairment

Carrying amount

At 31 December 2024

-

-

5

Debtors

Current

2024
£

2023
£

Trade debtors

30,303

47,148

Prepayments

113,615

71,371

Other debtors

264,392

239,991

 

408,310

358,510

 

Rapid Medtech Communications Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

6

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Trade creditors

222,763

244,395

Taxation and social security

-

5,573

Other creditors

141,313

133,615

364,076

383,583